<page_title> Herpes simplex research </page_title> <section_title> Vaccine candidates </section_title> <table> <cell> dl5-29 / ACAM-529 / HSV-529 <col_header> Vaccine </col_header> <col_header> Zostavax (VZV, shingles) </col_header> <col_header> Varivax, Varilrix(Varicella, C.Pox) </col_header> <col_header> Shingrix, GSK1437173A (VZV, shingles) </col_header> <col_header> Admedus HSV-2 therapeutic vaccine </col_header> </cell> <cell> HSV-2 replication-defective vaccine with UL5 and UL29 deleted <col_header> Vaccine Type </col_header> <row_header> dl5-29 / ACAM-529 / HSV-529 </row_header> </cell> </table>
The dl5-29 vaccine is also known under the name ACAM-529 or HSV-529, which is a replication-defective vaccine.